Investigation of Seroprevalence of Hepatitis B, Hepatitis C and HIV in Hemodialysis Patients
Aim: Impairments in the immune system of patients undergoing HD cause patients to be more sensitive to infection agents. The purpose of this study; to determine the seroprevalance of HBV, HCV and HIV in patients undergoing hemodialysis treatment. Materials and Methods: HBsAg, Anti-HBs, Anti-HBc IgM,...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Rabia Yılmaz
2021-07-01
|
Series: | Journal of Contemporary Medicine |
Subjects: | |
Online Access: | https://dergipark.org.tr/tr/pub/jcm/issue/61403/860950 |
id |
doaj-d8e62804aabd418b8f55cf280be8c711 |
---|---|
record_format |
Article |
spelling |
doaj-d8e62804aabd418b8f55cf280be8c7112021-08-29T10:32:42ZengRabia YılmazJournal of Contemporary Medicine2667-71802021-07-011144524551809Investigation of Seroprevalence of Hepatitis B, Hepatitis C and HIV in Hemodialysis PatientsDuygu Fındık0Gülperi Çelik1Rugıyya Samadzade2Salih Maçin3Ahmed Nsangou4SELCUK UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF BASIC MEDICAL SCIENCES, DEPARTMENT OF MICROBIOLOGYSELCUK UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINESELCUK UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF BASIC MEDICAL SCIENCES, DEPARTMENT OF MICROBIOLOGYSELCUK UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF BASIC MEDICAL SCIENCES, DEPARTMENT OF MICROBIOLOGYSELCUK UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF BASIC MEDICAL SCIENCES, DEPARTMENT OF MICROBIOLOGYAim: Impairments in the immune system of patients undergoing HD cause patients to be more sensitive to infection agents. The purpose of this study; to determine the seroprevalance of HBV, HCV and HIV in patients undergoing hemodialysis treatment. Materials and Methods: HBsAg, Anti-HBs, Anti-HBc IgM, Anti-HBc IgG, HBV-DNA, Anti-HCV, HCV-RNA and Anti-HIV parameters studied from serum samples of Chronic Kidney Patients (CKD) undergoing hemodialysis treatment at Selçuk University Faculty of Medicine It has been scanned retrospectively for ten years. Results: HBsAg was determined in 17 (0.40%) of 4155 hemodialysis patients and Anti-HBs was positive in 454 (11.2%). Anti-HCV was detected as positive in 14 (0.33%) serum. HBV-DNA was found to be positive in 13 (76.5%) of HBsAg positive HD patients and in 12 (85.7%) of Anti-HCV positive patients. Anti-HIV antibodies were not detected in any of the serum samples. Conclusions: The results of our study have shown that proper infection control measures in hemodialysis patients can reduce the contamination of infectious agents. In addition, factors such as vaccination scheme, inoculation site and dose should be selected appropriately, taking into account the immunosuppressive state of the patients.https://dergipark.org.tr/tr/pub/jcm/issue/61403/860950hemodialysischronic kidney patientshepatitis bhepatitis chivhemodiyalizkronik böbrek hastalığıhepatit bhepatit chiv |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Duygu Fındık Gülperi Çelik Rugıyya Samadzade Salih Maçin Ahmed Nsangou |
spellingShingle |
Duygu Fındık Gülperi Çelik Rugıyya Samadzade Salih Maçin Ahmed Nsangou Investigation of Seroprevalence of Hepatitis B, Hepatitis C and HIV in Hemodialysis Patients Journal of Contemporary Medicine hemodialysis chronic kidney patients hepatitis b hepatitis c hiv hemodiyaliz kronik böbrek hastalığı hepatit b hepatit c hiv |
author_facet |
Duygu Fındık Gülperi Çelik Rugıyya Samadzade Salih Maçin Ahmed Nsangou |
author_sort |
Duygu Fındık |
title |
Investigation of Seroprevalence of Hepatitis B, Hepatitis C and HIV in Hemodialysis Patients |
title_short |
Investigation of Seroprevalence of Hepatitis B, Hepatitis C and HIV in Hemodialysis Patients |
title_full |
Investigation of Seroprevalence of Hepatitis B, Hepatitis C and HIV in Hemodialysis Patients |
title_fullStr |
Investigation of Seroprevalence of Hepatitis B, Hepatitis C and HIV in Hemodialysis Patients |
title_full_unstemmed |
Investigation of Seroprevalence of Hepatitis B, Hepatitis C and HIV in Hemodialysis Patients |
title_sort |
investigation of seroprevalence of hepatitis b, hepatitis c and hiv in hemodialysis patients |
publisher |
Rabia Yılmaz |
series |
Journal of Contemporary Medicine |
issn |
2667-7180 |
publishDate |
2021-07-01 |
description |
Aim: Impairments in the immune system of patients undergoing HD cause patients to be more sensitive to infection agents. The purpose of this study; to determine the seroprevalance of HBV, HCV and HIV in patients undergoing hemodialysis treatment.
Materials and Methods: HBsAg, Anti-HBs, Anti-HBc IgM, Anti-HBc IgG, HBV-DNA, Anti-HCV, HCV-RNA and Anti-HIV parameters studied from serum samples of Chronic Kidney Patients (CKD) undergoing hemodialysis treatment at Selçuk University Faculty of Medicine It has been scanned retrospectively for ten years.
Results: HBsAg was determined in 17 (0.40%) of 4155 hemodialysis patients and Anti-HBs was positive in 454 (11.2%). Anti-HCV was detected as positive in 14 (0.33%) serum. HBV-DNA was found to be positive in 13 (76.5%) of HBsAg positive HD patients and in 12 (85.7%) of Anti-HCV positive patients. Anti-HIV antibodies were not detected in any of the serum samples.
Conclusions: The results of our study have shown that proper infection control measures in hemodialysis patients can reduce the contamination of infectious agents. In addition, factors such as vaccination scheme, inoculation site and dose should be selected appropriately, taking into account the immunosuppressive state of the patients. |
topic |
hemodialysis chronic kidney patients hepatitis b hepatitis c hiv hemodiyaliz kronik böbrek hastalığı hepatit b hepatit c hiv |
url |
https://dergipark.org.tr/tr/pub/jcm/issue/61403/860950 |
work_keys_str_mv |
AT duygufındık investigationofseroprevalenceofhepatitisbhepatitiscandhivinhemodialysispatients AT gulpericelik investigationofseroprevalenceofhepatitisbhepatitiscandhivinhemodialysispatients AT rugıyyasamadzade investigationofseroprevalenceofhepatitisbhepatitiscandhivinhemodialysispatients AT salihmacin investigationofseroprevalenceofhepatitisbhepatitiscandhivinhemodialysispatients AT ahmednsangou investigationofseroprevalenceofhepatitisbhepatitiscandhivinhemodialysispatients |
_version_ |
1721187312126132224 |